The His Optimised Pacing Evaluated for Heart Failure Trial (HOPE-HF).
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 198 participants.
Also called NCT02671903
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 198 participants
- Registry
-
NCT02671903
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02671903. Randomized; double masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2020-10-31 (actual). Results posted on 2025-02-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The His Optimised Pacing Evaluated for Heart Failure Trial (HOPE-HF).
- Acronym
- HOPE-HF
- Condition
- Heart Failure
- Intervention (Device)
- Pacemaker: AV optimised, His pacing.
- Lead sponsor
- Imperial College London
- Collaborator
- British Heart Foundation
- Collaborator
- Medtronic
Record details
- Record id
cardio:ct-nct02671903- Content hash
c5f259d9d5907136e68cd92d7e8cf4d3316fecce239ee8a6c035da5ed8938c11